Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Noridem Enterprises is a pharmaceutical company based in Nicosia, Cyprus, that specializes in the development, registration, and marketing of generic injectable products. As the international commercial arm of the Greek pharmaceutical group Demo S.A., Noridem manages an extensive portfolio of hospital-use medicines, including anesthesia agents, anti-infectives, and oncology treatments. The company provides a variety of injectable formats such as vials, ampoules, and pre-filled syringes, ensuring high-quality standards through its parent company's advanced manufacturing facilities. Noridem's strategic focus is on expanding its global footprint through licensing agreements and partnerships across Europe, the Middle East, and beyond. By offering a reliable supply of essential generic injectables, the company plays a vital role in supporting healthcare systems and improving patient access to critical care medications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Noridem Enterprises.